EU backs fully subcutaneous regimen of Remicade biobetter ntaylor Mon, 04/05/2021 – 12:35 More: EU backs fully subcutaneous regimen of Remicade biobetter Source: fierce
read moreLiquidia, Sandoz set to challenge United Therapeutics for subcutaneous Remodulin market ntaylor Mon, 04/05/2021 – 12:32 More: Liquidia, Sandoz set to challenge United Therapeutics for subcutaneous Remodulin market Source: fierce
read moreFurious Acadia takes shot at FDA, alleging sudden about-face in costly Nuplazid rejection aliu Mon, 04/05/2021 – 12:12 More: Furious Acadia takes shot at FDA, alleging sudden about-face in costly Nuplazid rejection Source: fierce
read moreCDMO Ajinomoto to bring AstraZeneca fill-finish work to San Diego plant fkansteiner Mon, 04/05/2021 – 11:11 More: CDMO Ajinomoto to bring AstraZeneca fill-finish work to San Diego plant Source: fierce
read moreCEO Dan O’Day, tasked with boosting Gilead’s oncology presence, scores $19M for a year focused on COVID esagonowsky Mon, 04/05/2021 – 11:02 More: CEO Dan O'Day, tasked with boosting Gilead's oncology presence, scores M for a year focused on COVID
read more© 1994 - 2026 B.M. Pharmaceuticals